Bleeding Edge

The Bleeding Edge is the only free newsletter that features investing insights from editor Colin Tedards. Here, Colin will share what he's watching in the market and which stocks you'll want on your radar.

CRISPR Research Inhibits 90% of All Coronaviruses

This “PAC-MAN” biotech gobbles up COVID-19 The race is on to see who will deliver the best 5G network What was Uber’s CEO thinking?! Dear Reader, I spent quite a bit of time over the weekend digging into the numbers on COVID-19 to get a handle on what is really happening right now. I continue […]

Why Tech Stocks Withstood the COVID-19 Crash

Here are my thoughts on the new space race I got a lot of pushback for this decision, but I’m glad I did it “Thank you, Lord Jesus, for good guidance via Jeff” Dear Reader, Welcome to our weekly mailbag edition of The Bleeding Edge. All week, you submitted your questions about the biggest trends […]